Wagg, A. et al. 2015. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Canadian Urological Association Journal. 9, 9-10 (Oct. 2015), 343–50. DOI:https://doi.org/10.5489/cuaj.3098.